Rvs could be better analgesics than anti-inflammatory drugs

  • 12/05/2017

The identification of specialised pro-resolving lipid mediators (SPMs) changed our understanding of the inflammatory response process.

Read more

The therapeutic potential of omega-3 in type 1 diabetes

  • 05/29/2017

Type 1 diabetes is a polygenic, autoimmune disease in which a subclass of T cells is involved in autoimmune attacks that cause the destruction of beta pancreatic cells.

Read more

The efficacy of a DHA-derived product in healing diabetic wounds

  • 09/27/2013

At the Swedish-American summit held at the Life Science Conference held in Stockholm in August this year, tissue damage therapy was discussed, in particular, accelerating wound healing and reconstruction of damaged t

Read more

Oral EPA reduced volumes of epicardial and abdominal visceral adipose tissue

  • 07/17/2014

Firstly, it is known that the volume of abdominal visceral tissue (AVT) is independently related to cardiovascular diseases and diabetes.

Read more

EPA in the treatment of hypertriglyceridaemia in diabetes type 2

  • 02/24/2015

Cardiovascular disease (CVD) is the main cause of death in patients with diabetes type 2 (with a rate two to four times higher than among the non-diabetic population).

Read more